Furthermore, most interestingly, recent studies, taking advantage of newly developed, non-commercially available reagents, clearly indicate that IDO protein expression is detectable in tumor cells in 20% of clinical PCa specimens (55). The gene discussed is IDO1; the disease is neoplasm.